Navigation Links
Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome
Date:11/20/2008

red pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia.

Committed to the future development and commercialization of iclaprim, Arpida has anticipated potential scenarios and instituted judicious business plans that allow for continued development of its portfolio of products. Arpida continues to work in close collaboration with regulatory authorities to obtain intravenous iclaprim market authorization in the United States and Europe.

About MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to most commonly available antibiotics.(i) MRSA infections occur most frequently among persons who have weakened immune systems in hospitals and healthcare facilities; however community-associated MRSA infections, such as abscesses, boils, and other pus-filled lesions, are increasingly being diagnosed in healthy people who have not been recently hospitalized or have undergone medical procedure.(iii), (ii)The most common antibiotic used to treat MRSA infections is vancomycin, but recent evidence suggests resistance to vancomycin is on the rise.(iii), (iv)

Approximately 2.3 million people in the United States acquire MRSA and 89.4 million people are colonized with S. aureus annually, according to the Centers for Disease Control and Prevention (CDC).(i), (v) An estimated 292,000 hospitalizations with a diagnosis of S. aureus infection occur annually in U.S. hospitals and, of these, approximately 126,000 hospitalizations are related to MRSA.(vi) MRSA is responsible for an average of 94,000 life-threatening infections and 18,650 deaths each year in the United States.(vii)

About Iclaprim

Iclaprim is an antibiotic currently in development for the treatment of serious infections requiring hospitalization caused by Gram-positive bacteria, including those caused by MRSA. Iclaprim was designed to meet a growing me
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Arpida Provides Further Comments on the Pivotal Phase III Trials
3. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
4. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
5. Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
6. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
7. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
8. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
9. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma Victims ... victims of mesothelioma get the best possible compensation, ... individuals with this rare cancer caused by exposure ... up-to-date information related to treatment options such as ... call the Mesothelioma Victims Center anytime at 866-714-6466. ...
(Date:5/22/2015)... , May 22, 2015 Research and ... the addition of the "Latest Regulations on ... report to their offering. This is ... issued a guidance on international multi-center clinical trials ... which has begun to be implemented on March ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... Nov. 4, 2011,   A unique treatment involving the ... John Hospital and Medical Center. SJH&MC is the first ... 20 centers nationwide to offer the treatment. ... has applications for a number of advanced cancers that ...
... SANTA BARBARA, Calif., Nov. 4, 2011 FindTheBest recently ... top Smart Rated products and services across an expanding ... a single score derived from a weighted compilation of ... product or service. While a top Smart Rating signifies ...
Cached Medicine Technology:St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System 2FindTheBest’s New Smart Badges Honor Health-related Products and Services 2FindTheBest’s New Smart Badges Honor Health-related Products and Services 3
(Date:5/25/2015)... Join Fiona's Soccer Camp at Novato High School's Tibi ... National Player, Fiona O'Sullivan will be on site to run ... coaching style. Fiona has three camps running this summer in ... Lynwood Elmentary School (June 15-19) and Hill Recreation Center (June ... 2015 - 1:00-3:00pm. Bring a Soccer Ball, Cleats and a ...
(Date:5/24/2015)... (PRWEB) May 25, 2015 Pacific Prime has announced ... part report looking at the cost of individual international health ... Article 2 looks at the cost of health insurance in six ... Focusing on, Hong Kong , ... the UAE , the UK , ...
(Date:5/24/2015)... NC (PRWEB) May 24, 2015 Scientists ... a paper on air quality compliance issues that may ... American workers. Surviving Mesothelioma has just posted an article ... now. , The group found airborne asbestos levels ... data collected between 1984 and 2011. , “Asbestos compliance ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/23/2015)... CA (PRWEB) May 23, 2015 Dr. David ... California, has just posted a new article to ... repair. As Dr Benvenuti explained in the fascinating ... enlarged plugs in their earlobes. , Known as “gauging,” the ... earlobe hole, which Dr. Benvenuti said will eventually stretch the ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2
... of the most vital treatment steps in recovery from hand ... August 2010 issue of the Journal of the American ... spend more time with the hand therapist than the orthopaedic ... long-term recovery. "Hand therapy is the critical link between ...
... MONDAY, Aug. 2 (HealthDay News) -- Children in an African ... until the age of 2 had vastly different gut bacteria ... diet and were breast-fed about only half that time. ... may predispose these children to become obese and develop allergies ...
... Boston, Mass. -- When published results are systematically tracked ... trials are the likeliest to be favorable to the ... Publishing in the August 3 issue of the ... more public disclosure about clinical drug trials at their ...
... and dentists have more in common than one might ... Both are subject to human error where small, individual ... A dental professor at the University of Michigan ... safety procedures in dental offices similar to procedures used ...
... HealthDay Reporter , MONDAY, August 2 (HealthDay News) ... higher than normal are at greater risk of developing ... hardening of the arteries leading to heart disease, a ... the common assumption that modestly high cholesterol levels are ...
... The Louisiana Tumor Registry (LTR) at the LSU Health ... been awarded a $12 million contract over seven years ... as a SEER (Surveillance, Epidemiology and End Results) Program-designated ... registries in the United States., "The SEER Program is ...
Cached Medicine News:Health News:Keeping patients 'in good hands' 2Health News:Western Diet Populates Kids' Stomachs With Bad Bacteria 2Health News:Western Diet Populates Kids' Stomachs With Bad Bacteria 3Health News:Drug trials funded by industry are more likely to publish favorable results 2Health News:Drug trials funded by industry are more likely to publish favorable results 3Health News:Pilot safety protocol could help dentists reduce errors 2Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 2Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 3Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 4Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 2Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: